@WHO: .@mdoherty_hiv talks about the new WHO guidelines advising countries to deliver long-acting cabotegravir for HIV prevention. ✅It is a safe and highly effective prevention option for people at substantial risk of #HIV infection. 📌 https://t.co/nBklLQboDZ #AIDS2022 https://t.co/Mkmdu3bsDA

http://twitter.com/WHO
via IFTTT